Two Sigma Investments, LP Cti Biopharma Corp Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$4.45 - $6.17 $157,369 - $218,195
-35,364 Reduced 18.07%
160,385 $963,000
Q3 2022

Nov 14, 2022
SELL
$5.36 - $7.43 $6.45 Million - $8.94 Million
-1,203,623 Reduced 86.01%
195,749 $1.14 Million
Q2 2022

Aug 15, 2022
SELL
$3.55 - $6.27 $1.49 Million - $2.63 Million
-419,590 Reduced 23.07%
1,399,372 $8.35 Million
Q1 2022

May 16, 2022
BUY
$1.9 - $5.23 $2.78 Million - $7.66 Million
1,464,744 Added 413.51%
1,818,962 $8.5 Million
Q4 2021

Feb 14, 2022
SELL
$1.44 - $2.86 $1.03 Million - $2.04 Million
-715,025 Reduced 66.87%
354,218 $878,000
Q3 2021

Nov 15, 2021
SELL
$2.25 - $3.18 $455,796 - $644,191
-202,576 Reduced 15.93%
1,069,243 $3.15 Million
Q2 2021

Aug 16, 2021
BUY
$2.16 - $2.62 $1.24 Million - $1.5 Million
572,907 Added 81.97%
1,271,819 $3.18 Million
Q1 2021

May 17, 2021
BUY
$2.68 - $3.8 $760,471 - $1.08 Million
283,758 Added 68.35%
698,912 $2.03 Million
Q4 2020

Feb 16, 2021
BUY
$2.48 - $3.8 $593,895 - $910,001
239,474 Added 136.31%
415,154 $1.34 Million
Q3 2020

Nov 16, 2020
BUY
$1.02 - $2.15 $140,951 - $297,104
138,188 Added 368.58%
175,680 $378,000
Q2 2020

Aug 14, 2020
SELL
$0.88 - $1.32 $1,408 - $2,112
-1,600 Reduced 4.09%
37,492 $43,000
Q1 2020

May 15, 2020
SELL
$0.69 - $1.54 $21,294 - $47,525
-30,861 Reduced 44.12%
39,092 $36,000
Q4 2019

Feb 14, 2020
SELL
$0.72 - $1.64 $27,002 - $61,504
-37,503 Reduced 34.9%
69,953 $111,000
Q3 2019

Nov 14, 2019
SELL
$0.64 - $0.92 $14,307 - $20,567
-22,356 Reduced 17.22%
107,456 $90,000
Q2 2019

Aug 14, 2019
SELL
$0.8 - $1.03 $36,241 - $46,661
-45,302 Reduced 25.87%
129,812 $112,000
Q1 2019

May 15, 2019
SELL
$0.9 - $1.37 $40,009 - $60,903
-44,455 Reduced 20.25%
175,114 $170,000
Q4 2018

Feb 14, 2019
BUY
$0.73 - $2.19 $7,854 - $23,562
10,759 Added 5.15%
219,569 $161,000
Q3 2018

Nov 14, 2018
BUY
$1.72 - $5.24 $359,153 - $1.09 Million
208,810 New
208,810 $451,000
Q2 2018

Aug 14, 2018
SELL
$3.81 - $5.26 $305,824 - $422,214
-80,269 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$2.7 - $4.06 $216,726 - $325,892
80,269 New
80,269 $313,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email